XML 64 R57.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Deficit - Schedule Of Activity Under The Plans (Details)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Stockholders' Equity Note [Abstract]    
Balance at beginning of period | shares 4,746,527  
Options granted | shares 1,713,753  
Options exercised | shares (348,943)  
Options forfeited | shares (434,439)  
Balance at end of period | shares 5,676,898 4,746,527
Vested or expected to vest at end of period | shares 5,676,898  
Exercisable at end of period | shares 2,555,661  
Balance at beginning of period | $ / shares $ 4.04  
Options granted , Weighted average exercise price | $ / shares 11.68  
Options exercised, Weighted average exercise price | $ / shares 2.69  
Options forfeited , Weighted average exercise price | $ / shares 5.12  
Balance at end of period | $ / shares 6.35 $ 4.04
Weighted-average exercise price, vested or expected to vest at end of period | $ / shares 6.35  
Weighted-average exercise price, exercisable at end of period | $ / shares $ 3.76  
Weighted-average remaining contractual life in years 7 years 10 months 28 days 8 years 2 months 1 day
Weighted-average remaining contractual life in years, vested, and expected to vest 7 years 10 months 28 days  
Weighted-average remaining contractual life in years, exercisable at end of period 6 years 9 months  
Aggregate intrinsic value | $ $ 59,386 $ 13,383
Aggregate intrinsic value, Options exercised | $ 33,358  
Aggregate intrinsic value, vested or expected to vest at end of period | $ $ 59,386